113 related articles for article (PubMed ID: 6680213)
1. Causes of failure of radiotherapy in head and neck cancer.
Peters LJ; Fletcher GH
Radiother Oncol; 1983 Aug; 1(1):53-63. PubMed ID: 6680213
[TBL] [Abstract][Full Text] [Related]
2. Tumor radioresistance in clinical radiotherapy.
Peters LJ; Withers HR; Thames HD; Fletcher GH
Int J Radiat Oncol Biol Phys; 1982 Jan; 8(1):101-8. PubMed ID: 7061244
[TBL] [Abstract][Full Text] [Related]
3. Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy.
Weichselbaum RR; Beckett MA; Schwartz JL; Dritschilo A
Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):575-9. PubMed ID: 3417487
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients.
de Jong MC; Ten Hoeve JJ; Grénman R; Wessels LF; Kerkhoven R; Te Riele H; van den Brekel MW; Verheij M; Begg AC
Clin Cancer Res; 2015 Dec; 21(24):5630-8. PubMed ID: 26265694
[TBL] [Abstract][Full Text] [Related]
5. Oxygen and Perfusion Kinetics in Response to Fractionated Radiation Therapy in FaDu Head and Neck Cancer Xenografts Are Related to Treatment Outcome.
Hu F; Vishwanath K; Salama JK; Erkanli A; Peterson B; Oleson JR; Lee WT; Brizel DM; Ramanujam N; Dewhirst MW
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):462-469. PubMed ID: 27598811
[TBL] [Abstract][Full Text] [Related]
6. Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients.
Weichselbaum RR; Dahlberg W; Beckett M; Karrison T; Miller D; Clark J; Ervin TJ
Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2684-8. PubMed ID: 3458227
[TBL] [Abstract][Full Text] [Related]
7. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
8. Micro-RNAs, the Cornerstones of the Future of Radiobiology in Head and Neck Cancers?
Mireștean CC; Iancu RI; Iancu DPT
Curr Oncol; 2022 Feb; 29(2):816-833. PubMed ID: 35200568
[TBL] [Abstract][Full Text] [Related]
9. Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers.
Björk-Eriksson T; West C; Karlsson E; Mercke C
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):13-9. PubMed ID: 10656366
[TBL] [Abstract][Full Text] [Related]
10. Radiobiological predictors of tumor and acute normal tissue response in radiotherapy for head and neck cancers.
Maciejewski B; Skladowski K; Zajusz A
Neoplasma; 1991; 38(5):513-22. PubMed ID: 1956467
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
12. Radioresistant tumor cell lines derived from head and neck radiation failures.
Weichselbaum RR; Beckett MA; Vijayakumar S; Ahmed-Swan S; Dritschilo A; Schwartz JL; Moran WJ; Goldman ME; Tybor AG; Vokes EE
Head Neck; 1989; 11(4):343-8. PubMed ID: 2753702
[TBL] [Abstract][Full Text] [Related]
13. Cellular X-ray repair parameters of early passage squamous cell carcinoma lines derived from patients with known responses to radiotherapy.
Weichselbaum R; Dahlberg W; Little JB; Ervin TJ; Miller D; Hellman S; Rheinwald JG
Br J Cancer; 1984 May; 49(5):595-601. PubMed ID: 6722007
[TBL] [Abstract][Full Text] [Related]
14. Apparent rates of proliferation of acutely responding normal tissues during radiotherapy of head and neck cancer.
Fowler JF
Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1451-6. PubMed ID: 1938553
[TBL] [Abstract][Full Text] [Related]
15. Brachytherapy for radiotherapy-resistant head and neck cancer: A review of a single center experience.
Hazkani I; Rabinovics N; Limon D; Silvern D; Koren S; Hadar T; Bachar G; Shpitzer T; Popovtzer A
Laryngoscope; 2016 Oct; 126(10):2246-51. PubMed ID: 26928864
[TBL] [Abstract][Full Text] [Related]
16. Tumor control probability (TCP) and normal tissue complication probability (NTCP) in head and neck cancer.
Grégoire V
Rays; 2005; 30(2):105-8. PubMed ID: 16294902
[TBL] [Abstract][Full Text] [Related]
17. Comparison of predicted and clinical response to radiotherapy: a radiobiology modelling study.
Hedman M; Bjork-Eriksson T; Mercke C; West C; Hesselius P; Brodin O
Acta Oncol; 2009; 48(4):584-90. PubMed ID: 19107620
[TBL] [Abstract][Full Text] [Related]
18. Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy.
Geara FB; Peters LJ; Ang KK; Garden AS; Tucker SL; Levy LB; Brown BW
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):455-62. PubMed ID: 8655367
[TBL] [Abstract][Full Text] [Related]
19. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results.
Puthawala A; Nisar Syed AM; Gamie S; Chen YJ; Londrc A; Nixon V
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):354-62. PubMed ID: 11567809
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapeutic management of locally advanced head and neck cancer.
Laskar SG; Agarwal JP; Srinivas C; Dinshaw KA
Expert Rev Anticancer Ther; 2006 Mar; 6(3):405-17. PubMed ID: 16503857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
